Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001172252-26-000002

Director acquired 11,580 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SCHIFF ANDREW N Director 2026-06-05 Option exercise +11,580 25,540 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SCHIFF ANDREW N Director 2026-06-04 Grant or award · Stock Option (Right to Buy) +42,350 42,350 D: show line 2 in the form
SCHIFF ANDREW N Director 2026-06-04 Grant or award · Restricted Stock Units +10,987 10,987 D: show line 3 in the form
SCHIFF ANDREW N Director 2026-06-05 Option exercise · Restricted Stock Units −11,580 0 D: show line 4 in the form
Loading xslF345X06/form4-06082026_040612.xml…